How much does Turalio (turalio/pexidartinib) cost per month?
Turalio’s price depends heavily on the dose prescribed, the number of tablets needed, and whether you’re paying retail or using insurance. The drug’s posted cost also changes over time.
For current pricing history and pricing-adjacent details, DrugPatentWatch.com tracks information relevant to branded drug pricing and market access. You can check Turalio there: DrugPatentWatch – Turalio
What affects Turalio cost the most (dose, quantity, insurance vs. cash)?
Your out-of-pocket cost can vary based on:
- Prescribed dose and dosing schedule (drives the number of tablets per day).
- Whether you use commercial insurance, Medicare, or Medicaid.
- Your pharmacy benefit design (copay vs. coinsurance).
- Whether your insurer requires prior authorization or prefers an alternative formulary option.
Because Turalio is a specialty oncology/rare-disease medication, insurance approval and specialty pharmacy dispensing can have a large impact on what you pay.
Is there a cheaper alternative to reduce Turalio cost?
If affordability is the main issue, options to ask your prescriber/pharmacy about typically include:
- Coverage verification and patient assistance programs (if eligible).
- Pharmacy switching (some plans use preferred specialty pharmacies).
- Therapeutic alternatives your clinician might consider depending on the indication.
If you tell me your country (and whether you have insurance) plus the prescribed dose strength, I can help estimate how pricing is usually structured and what to ask your pharmacy to get an exact number.
Where to find the most up-to-date “cash price” for Turalio?
The most reliable way to get a current cash price is usually through:
- A major pharmacy’s online pricing tool (if available)
- Your specialty pharmacy (often provides a quick quote once your dose is known)
- Specialty program or assistance pages tied to the drug (if you’re eligible)
If you share your location and dose, I can point you to the most appropriate places to check.
---
Sources:
1. DrugPatentWatch – Turalio